184 related articles for article (PubMed ID: 12631292)
21. Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy.
Chun TH; Itoh H; Subramanian L; Iñiguez-Lluhí JA; Nakao K
Circ Res; 2003 Jun; 92(11):1201-8. PubMed ID: 12750312
[TBL] [Abstract][Full Text] [Related]
22. Dynamin interacts with members of the sumoylation machinery.
Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
[TBL] [Abstract][Full Text] [Related]
23. RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.
Yan J; Yang XP; Kim YS; Joo JH; Jetten AM
Biochem Biophys Res Commun; 2007 Oct; 362(1):132-138. PubMed ID: 17698038
[TBL] [Abstract][Full Text] [Related]
24. Post-translational modification of Rta of Epstein-Barr virus by SUMO-1.
Chang LK; Lee YH; Cheng TS; Hong YR; Lu PJ; Wang JJ; Wang WH; Kuo CW; Li SS; Liu ST
J Biol Chem; 2004 Sep; 279(37):38803-12. PubMed ID: 15229220
[TBL] [Abstract][Full Text] [Related]
25. SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription.
Tiefenbach J; Novac N; Ducasse M; Eck M; Melchior F; Heinzel T
Mol Biol Cell; 2006 Apr; 17(4):1643-51. PubMed ID: 16421255
[TBL] [Abstract][Full Text] [Related]
26. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
[TBL] [Abstract][Full Text] [Related]
27. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
Buschmann T; Lerner D; Lee CG; Ronai Z
J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
[TBL] [Abstract][Full Text] [Related]
28. The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation.
Weger S; Hammer E; Engstler M
Exp Cell Res; 2003 Oct; 290(1):13-27. PubMed ID: 14516784
[TBL] [Abstract][Full Text] [Related]
29. A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis.
Nelson V; Davis GE; Maxwell SA
Apoptosis; 2001 Jun; 6(3):221-34. PubMed ID: 11388671
[TBL] [Abstract][Full Text] [Related]
30. Fbxw5 suppresses nuclear c-Myb activity via DDB1-Cul4-Rbx1 ligase-mediated sumoylation.
Kanei-Ishii C; Nomura T; Egoh A; Ishii S
Biochem Biophys Res Commun; 2012 Sep; 426(1):59-64. PubMed ID: 22910413
[TBL] [Abstract][Full Text] [Related]
31. A SUMO-regulated activation function controls synergy of c-Myb through a repressor-activator switch leading to differential p300 recruitment.
Molvaersmyr AK; Saether T; Gilfillan S; Lorenzo PI; Kvaløy H; Matre V; Gabrielsen OS
Nucleic Acids Res; 2010 Aug; 38(15):4970-84. PubMed ID: 20385574
[TBL] [Abstract][Full Text] [Related]
32. Repression of E1AF transcriptional activity by sumoylation and PIASy.
Nishida T; Terashima M; Fukami K; Yamada Y
Biochem Biophys Res Commun; 2007 Aug; 360(1):226-32. PubMed ID: 17585876
[TBL] [Abstract][Full Text] [Related]
33. PIASy-mediated repression of the Ets-1 is independent of its sumoylation.
Nishida T; Terashima M; Fukami K
Biochem Biophys Res Commun; 2006 Jul; 345(4):1536-46. PubMed ID: 16729975
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
35. Sumoylated SnoN represses transcription in a promoter-specific manner.
Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
[TBL] [Abstract][Full Text] [Related]
36. Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1.
Kang ES; Park CW; Chung JH
Biochem Biophys Res Commun; 2001 Dec; 289(4):862-8. PubMed ID: 11735126
[TBL] [Abstract][Full Text] [Related]
37. PIAS1 binds p300 and behaves as a coactivator or corepressor of the transcription factor c-Myb dependent on SUMO-status.
Ledsaak M; Bengtsen M; Molværsmyr AK; Fuglerud BM; Matre V; Eskeland R; Gabrielsen OS
Biochim Biophys Acta; 2016 May; 1859(5):705-18. PubMed ID: 27032383
[TBL] [Abstract][Full Text] [Related]
38. Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity.
Bies J; Markus J; Wolff L
J Biol Chem; 2002 Mar; 277(11):8999-9009. PubMed ID: 11779867
[TBL] [Abstract][Full Text] [Related]
39. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.
Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783
[TBL] [Abstract][Full Text] [Related]
40. PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes.
Azuma Y; Arnaoutov A; Anan T; Dasso M
EMBO J; 2005 Jun; 24(12):2172-82. PubMed ID: 15933717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
